Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125955401 | 12595540 | 1 | I | 20160720 | 20160726 | 20160726 | PER | US-CELGENEUS-USA-2016075401 | CELGENE | 0.00 | M | Y | 85.08000 | KG | 20160726 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125955401 | 12595540 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | B0028AH | 20785 | 50 | MG | CAPSULES | |||||
| 125955401 | 12595540 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | B0028AH | 20785 | 50 | MG | CAPSULES | |||||
| 125955401 | 12595540 | 3 | C | VELCADE | BORTEZOMIB | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 6 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 7 | C | LOTENSIN | BENAZEPRIL HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 8 | C | Fish Oil | FISH OIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 9 | C | Multivitamin | VITAMINS | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125955401 | 12595540 | 10 | C | Iron | IRON | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125955401 | 12595540 | 1 | Plasma cell myeloma |
| 125955401 | 12595540 | 3 | Plasma cell myeloma |
| 125955401 | 12595540 | 4 | Plasma cell myeloma |
| 125955401 | 12595540 | 5 | Product used for unknown indication |
| 125955401 | 12595540 | 6 | Product used for unknown indication |
| 125955401 | 12595540 | 7 | Product used for unknown indication |
| 125955401 | 12595540 | 8 | Product used for unknown indication |
| 125955401 | 12595540 | 9 | Product used for unknown indication |
| 125955401 | 12595540 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125955401 | 12595540 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125955401 | 12595540 | Cerebrovascular accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125955401 | 12595540 | 1 | 20151013 | 0 | ||
| 125955401 | 12595540 | 2 | 201601 | 0 |